Bunkerhill MAC vs Reveal LINQ Insertable Cardiac Monitor

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Bunkerhill Health
VS

AI Verdict

Tool A, Bunkerhill MAC, is designed for identifying cardiovascular risk by detecting and quantifying mitral annular calcification on CT scans, integrating with existing clinical systems. In contrast, Tool B, the Reveal LINQ Insertable Cardiac Monitor, is an implantable device that uses AI to provide long-term, accurate ECG monitoring for arrhythmias. While both leverage AI in cardiology, they address different clinical needs and utilize distinct technological approaches.

Choose Bunkerhill MAC if…

Choose Bunkerhill MAC if you need to proactively identify patients at increased cardiovascular risk by leveraging existing routine CT scans. This AI algorithm is ideal for automatically detecting and quantifying mitral annular calcification (MAC), enabling early risk stratification and seamless integration into care coordination workflows within your EHR and the Carebricks platform.

View Bunkerhill MAC →

Choose Reveal LINQ Insertable Cardiac Monitor if…

Choose the Reveal LINQ Insertable Cardiac Monitor if you require long-term, continuous cardiac monitoring for patients experiencing infrequent or unexplained symptoms like syncope or suspected arrhythmias such as atrial fibrillation. Its implantable nature and AI-powered algorithms reduce false alerts, providing accurate and extended ECG data for definitive diagnosis and management.

View Reveal LINQ Insertable Cardiac Monitor →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Bunkerhill MAC Reveal LINQ Insertable Cardiac Monitor
Pricing Unknown Contact vendor
Deployment Cloud-based, integrates with EHRs. Implantable device with data transmitted to a cloud-based platform (CareLink™ network) via patient smartphone app or home communicator.
BAA Available Yes AI-estimated Yes AI-estimated
FDA Status Cleared AI-estimated Yes AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Bunkerhill MAC

Tool A offers superior usability for clinicians by seamlessly integrating into existing EHRs and clinical workflows, analyzing routine scans without requiring new patient-facing devices. Its Carebricks Chat feature further enhances usability by providing conversational access to comprehensive patient data, streamlining information retrieval for providers.

Clinical Value

Reveal LINQ Insertable Cardiac Monitor

Tool B provides a direct and quantifiable clinical benefit by significantly reducing false alerts in cardiac monitoring, which enhances diagnostic accuracy and saves substantial clinician time. While Tool A offers valuable early risk identification for an often-missed condition, Tool B's immediate impact on diagnostic efficiency for prevalent arrhythmias provides a more tangible and widespread improvement in clinical workflow.

Pricing & Value

Tie

Both tools require direct contact with their respective vendors for pricing information, making it impossible to conduct a head-to-head comparison of their cost-effectiveness or overall value. Neither company provides public transparency regarding their pricing structures.

Enterprise Readiness

Reveal LINQ Insertable Cardiac Monitor

Tool B explicitly states its HIPAA compliance and the availability of a Business Associate Agreement (BAA), which are non-negotiable and critical assurances for enterprise adoption in healthcare. While Tool A demonstrates strong internal security practices, its lack of explicit public statements regarding HIPAA compliance and BAA in its primary description gives Tool B a clearer advantage in enterprise readiness documentation.

Innovation

Bunkerhill MAC

Tool A demonstrates greater innovation by leveraging 'Generative AI for clinical reasoning and action' across a broader spectrum of patient data, including unstructured notes, to automate next steps and provide conversational access to patient records. This represents a more expansive and advanced application of AI beyond specific detection or filtering tasks, indicating a forward-thinking approach to clinical decision support.

Support & Docs

Reveal LINQ Insertable Cardiac Monitor

Tool B, as a product from a large medical device company, offers clearly defined and publicly accessible support channels, including technical and patient services phone numbers, and a comprehensive online library of manuals and patient education materials. Tool A lacks specific information on its support and documentation resources, making Tool B the clear winner in this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Bunkerhill MAC Reveal LINQ Insertable Cardiac Monitor
Name Bunkerhill MAC Reveal LINQ Insertable Cardiac Monitor
Company Bunkerhill Health Medtronic
Description Summary FDA-cleared AI algorithm that detects and quantifies mitral annular calcification (MAC) on routine CT scans, aiding early cardiovascular risk identification and care coordination within the Carebricks platform. Insertable Cardiac Monitor (ICM) with AccuRhythmu2122 AI algorithms providing long-term, accurate heart monitoring by using deep learning AI to reduce false alerts and enhance diagnostic yield.
Categories Cardiology AI, Clinical Decision Support & Reference Cardiology AI, Wearables & Remote Monitoring (RPM)
Specialties Cardiology, Radiology Cardiology, Pediatrics
Key Feature (AI Focus) AI-powered detection and quantification of Mitral Annular Calcification (MAC) AccuRhythmu2122 AI algorithms for reduced false alerts (AF and Pause)

Videos

Demos, reviews, and walkthroughs featuring Bunkerhill MAC and Reveal LINQ Insertable Cardiac Monitor.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Bunkerhill MAC is an AI algorithm designed to detect and quantify mitral annular calcification (MAC) on routine CT scans, aiding in early cardiovascular risk identification. The Reveal LINQ Insertable Cardiac Monitor (ICM) provides long-term, accurate heart monitoring to enhance diagnostic yield for conditions like atrial fibrillation and syncope.
Bunkerhill MAC utilizes an FDA-cleared AI algorithm to analyze routine CT scans for the detection and quantification of MAC. The Reveal LINQ ICM incorporates AccuRhythmu2122 AI algorithms to reduce false alerts and enhance diagnostic yield during continuous subcutaneous ECG monitoring.
Bunkerhill MAC analyzes routine, non-gated chest CT scans to identify and quantify MAC. The Reveal LINQ ICM performs continuous, long-term subcutaneous ECG monitoring to collect heart rhythm data.
Bunkerhill MAC is primarily relevant for Cardiology and Radiology specialties due to its use of CT scans for cardiovascular risk assessment. The Reveal LINQ ICM is primarily used within Cardiology and Pediatrics for long-term heart monitoring.
Bunkerhill MAC aids in early cardiovascular risk identification and supports automated workflows for follow-up and care coordination through its integration with the Carebricks platform. The Reveal LINQ ICM offers reduced false alerts for AF and Pause, enhanced diagnostic yield, and remote programming capabilities for efficient long-term heart monitoring.
AI Tool Finder
AI-powered search. Results may not be comprehensive.